Innovations in Small Cell Lung Cancer: ADRIATIC Study

episode

Cleveland Clinic Cancer Advances not yet transcribed

▲ 0

Transcript

This episode hasn't been transcribed yet Upvotes decide what gets transcribed next — 0 so far. Sign in to upvote

Related

recent transcribed audio

Transrapid, Flugtaxis, Hyperloop – Warum es neuartige Verkehrstechnik so schwer hat 28 min · 22 Sep 2026 · Das Wissen | SWR

NPR News: 09-21-2026 1PM EDT 5 min · 21 Sep 2026 · NPR News Now

1PM ET 09/21/2026 Newscast 3 min · 21 Sep 2026 · Fox News Hourly Update

The Invisible Front_ Geoeconomics and the New World Order 3 min · 21 Sep 2026 · Conspiracy Theories Exploring The Unseen

The Intellectual Glow Up: How To Think Deeper 29 min · 21 Sep 2026 · Two Broke Chicks

Why Listening Beats Every Argument 1h 44m · 21 Sep 2026 · The Jordan B. Peterson Podcast

Report any issue

Source

Recorded08 Aug 2024

Publisherfeeds.buzzsprout.com

Handlerec:1648176

Show notes

Lukas Delasos, DO, Medical Oncologist at Cleveland Clinic, joins the Cancer Advances podcast to talk about the ADRIATRIC study. Dr. Delasos shares his insights on small cell lung cancer, detailing its aggressive nature, current treatment paradigms, and the promising results from the ADRIATIC study involving durvalumab as a consolidation therapy.

Ask this episode

“What did the council decide on item 42?” — answered with the speaker and the moment.

Sign in